Jane Street
CSBR icon

Jane Street’s Champions Oncology CSBR Stock Holding History

Jane Street’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Sell
23,200
-12,900
-36% -$81.9K ﹤0.01% 10475
2025
Q4 		$249K Buy
+36,100
New +$240K ﹤0.01% 9251

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Jane Street's CSBR Position: Q3 2025 in Review

Jane Street sold out of Champions Oncology (CSBR) in Q3 2025, closing a stake of 17,667 shares — an estimated $130K sold.

Jane Street first reported a position in CSBR in Q1 2025 and held it in 2 quarters. The position peaked at $200K in Q1 2025. 27 funds tracked by Wall St. Rank hold CSBR as of Q3 2025.

  • Jane Street reported no remaining Champions Oncology position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 17,667 Champions Oncology shares in Q3 2025, an estimated $130K.
  • Jane Street first reported a position in Champions Oncology in Q1 2025 and held it in 2 quarters.
  • Jane Street's Champions Oncology position peaked at $200K in Q1 2025.
  • 27 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.